In a report published today by the Build with CaRe consortium, the researchers propose a new EU target of a 40 per cent reduction in primary energy demand by 2050. The existing target is a 20 per cent improvement in energy efficiency by 2020, but the EU is currently on track to achieve only half of this.
The report by Dr Bruce Tofield and Martin Ingham, associate consultants at UEA's Adapt Low Carbon Group concludes that radically improving the energy efficiency of new and existing buildings is key to reducing global greenhouse gas emissions, and Europe should be leading the way.
A 40 per cent reduction by 2050 for the EU is in line with the ambitions of new Energy and Climate Change Secretary Ed Davey. At the launch of his new Energy Efficiency Deployment Office earlier this month, he called for a cut in UK energy use of between a third and a half by 2050.
"Buildings are responsible for 40 per cent of Europe's energy-related greenhouse gas emissions, so overhauling their energy efficiency represents the greatest opportunity for energy saving and greenhouse gas reduction," said Dr Tofield.
"By making its building stock energy efficient, the EU can demonstrate that economic growth is consistent with reduced energy demand and lead the transition to a sustainable world. A long-term target of 40 per cent would galvanise the near-term action on energy efficiency that is essential if action to tackle potentially dangerous climate change is to succeed."
The consensus among climate scientists is that global warming above 2 degrees can only be avoided if global greenhouse emissions begin to reduce before 2020. However, current projections show fossil fuel use and greenhouse gas emissions continuing to increase for decades.
Dr Tofield said he agreed with the EU Commission's Energy Roadmap 2050 that a big reduction in energy demand is achievable and that very energy efficient buildings should become the norm, but he said many barriers remained.
"The biggest barrier is lack of political will to accelerate progress in energy efficiency," he said.
"New build ambition is insufficient and the rate of building refurbishment to achieve high standards of energy efficiency is far too low. Political will to transform buildings will demonstrate EU leadership on climate action post-Durban. Cities across the EU can lead this change."
Build with CaRe is a consortium of local authorities and universities from five countries across the North Sea region, funded partly by the European Regional Development Fund. Its aim is to make energy-efficient building design the mainstream. A key strategy is the promotion of the innovative 'passivhaus' concept which can reduce energy use for heating and cooling buildings by 90 per cent. Adopting passivhaus quality as the building industry standard for both new build and refurbishment of existing buildings will also bring financial and well-being benefits for occupants.
John Helmfridsson, a passive house expert at Passivhuscentrum in Västra Götaland, Sweden, and a Build with CaRe partner, agreed: "Energy efficiency is becoming a main competitive advantage to countries and companies investing in the issue. To not use or further develop knowledge would be hazardous, not only to the environment but to the European economy."
'Refurbishing Europe: An EU strategy for energy efficiency and climate action led by building refurbishment' by Bruce Tofield and Martin Ingham is published on Monday February 27. For more information or to download the report, visit www.buildwithcare.eu or www.lcic.com
Smart windows that self-illuminate on rainy days
29.05.2020 | Pohang University of Science & Technology (POSTECH)
Skoltech scientists get a sneak peek of a key process in battery 'life'
28.05.2020 | Skolkovo Institute of Science and Technology (Skoltech)
In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".
Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...
Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.
researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...
Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.
When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...
Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.
Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...
Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.
A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...
19.05.2020 | Event News
07.04.2020 | Event News
06.04.2020 | Event News
29.05.2020 | Materials Sciences
29.05.2020 | Materials Sciences
29.05.2020 | Power and Electrical Engineering